Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,800 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,293 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,200 | | cost reimbursement |
Fort Dodge Laboratories, Inc. | Zoetis | Iowa | state | 2007 | $2,617,500 | | enterprise zone |
Abraxis BioScience | Bristol-Myers Squibb | Iowa | state | 2008 | $662,500 | | enterprise zone |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | state | 2010 | $101,000 | | Enterprise zone |
IDEXX Distribution Inc | IDEXX Laboratories | Maine | state | 2010 | undisclosed | | enterprise zone |
IDEXX Operations Inc | IDEXX Laboratories | Maine | state | 2010 | undisclosed | | enterprise zone |
IDEXX Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2010 | undisclosed | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2006 | $2,697,365 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2006 | $1,599,567 | | enterprise zone |
Regeneron Pharmaceuticals Inc. | Regeneron Pharmaceuticals | New York | state | 2006 | $200,144 | | enterprise zone |
Clay-Park Labs Inc. | Perrigo | New York | state | 2006 | $150,000 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2007 | $2,870,000 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2007 | $1,123,304 | | enterprise zone |
Regeneron Pharmaceuticals Inc. | Regeneron Pharmaceuticals | New York | state | 2007 | $416,897 | | enterprise zone |
BEN VENUE LABORATORIES | Boehringer Ingelheim | Ohio | state | 2001 | $2,439,160 | | enterprise zone |
BEN VENUE LABORATORIES, INC. | Boehringer Ingelheim | Ohio | state | 2005 | $2,246,703 | | enterprise zone |
BEN VENUE LABORATORIES, INC. | Boehringer Ingelheim | Ohio | state | 2006 | undisclosed | | enterprise zone |
BEN VENUE LABORATORIES | Boehringer Ingelheim | Ohio | state | 2007 | undisclosed | | enterprise zone |
PharmaForce, Inc. | Daiichi Sankyo | Ohio | state | 2008 | undisclosed | | enterprise zone |
CSL Plasma, Inc. | CSL Limited | Arizona | state | 2010 | undisclosed | | enterprise zone |
CSL Plasma, Inc. | CSL Limited | Arizona | state | 2010 | undisclosed | | enterprise zone |
Cangene bioPharma, Inc. | Emergent BioSolutions | Maryland | local | 2009 | undisclosed | | enterprise zone |
Boehringer Ingelheim Roxane, Inc./Roxane Laboratories, Inc. | Hikma Pharmaceuticals | Ohio | state | 2012 | undisclosed | | enterprise zone |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2002 | undisclosed | | enterprise zone |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2002 | undisclosed | | enterprise zone |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2003 | undisclosed | | enterprise zone |
ETHICON INC | Johnson & Johnson | Texas | state | 2002 | undisclosed | | enterprise zone |
IDEXX Distribution Inc | IDEXX Laboratories | Maine | state | 2012 | undisclosed | | enterprise zone |
IDEXX Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2017 | undisclosed | | enterprise zone |
IDEXX Operations Inc | IDEXX Laboratories | Maine | state | 2012 | undisclosed | | enterprise zone |
IDEXX Reference Laboratories, Inc | IDEXX Laboratories | Maine | state | 2012 | undisclosed | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2003 | $8,249 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2001 | $944,526 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2002 | $95,858 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2003 | $5,679,250 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2011 | $54,000 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2012 | $191,566 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2013 | $191,000 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2014 | $63,126 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2008 | $290,648 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2008 | $290,648 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2009 | $877,386 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2009 | $877,386 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2010 | $794,527 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2010 | $794,527 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2010 | $1,951,103 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2011 | $316,824 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2011 | $1,107,208 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2011 | $1,107,208 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2012 | $372,801 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2012 | $1,515,349 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2012 | $1,515,349 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $197,815 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $914,531 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2013 | $914,531 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2014 | $207,247 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2014 | $5,509,471 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2014 | $5,509,471 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2015 | $95,771 | | enterprise zone |